Clinical Trials Logo

Filter by:
NCT ID: NCT05618327 Recruiting - Clinical trials for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Start date: February 13, 2023
Phase: Phase 1
Study type: Interventional

This is an open phase I clinical study to evaluate the safety, tolerability, pharmacokinetic (PK) profile, pharmacodynamic (PD) profile, immunogenicity, and preliminary efficacy of JS203 in patients with relapsed/refractory B-cell non-Hodgkin's lymphoma. The study is divided into three phases: a dose-escalation phase, a dose-expansion phase, and an efficacy expansion phase.

NCT ID: NCT05618041 Recruiting - Multiple Myeloma Clinical Trials

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

Start date: September 7, 2022
Phase: N/A
Study type: Interventional

To evaluate the tolerability and safety of CAR-T technology in patients with relapsed or refractory hematolymphoid malignancies.

NCT ID: NCT05617872 Recruiting - Pancreatic Cancer Clinical Trials

Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the feasibility of collecting pancreatic juice through duodenal aspiration by ultrasound endoscopy (EUS) for molecular marker testing after intraduodenal infusion of vinegar in patients with suspected pancreatic cancer and who are scheduled to have endoscopic ultrasound with fine needle aspiration (EUS-FNA). The main questions it aims to answer are: - Is vinegar-induced collection of duodenal pancreatic juice via endoscopic ultrasound feasible? - What is the best operating condition (amount of vinegar, collection time, etc.) of vinegar-induced collection of duodenal pancreatic juice via endoscopic ultrasound? Participants will have EUS as scheduled, during which different amount of vinegar will be infused into duodenum and then pancreatic juice be collected for different time via suction by EUS. Researchers will compare the amount of collected pancreatic juice and molecular marker level in different groups to determine the best operating condition for vinegar-induced collection of duodenal pancreatic juice via endoscopic ultrasound.

NCT ID: NCT05617859 Recruiting - Sexuality Clinical Trials

Lenvatinib for Advanced Bone and Soft Tissue Sarcoma

Start date: April 30, 2023
Phase: Phase 2
Study type: Interventional

A total of 60 patients with metastatic/surgically unresectable bone and soft tissue sarcomas who had previously received multi-target TKI therapy and failed were enrolled to evaluate the efficacy and safety.

NCT ID: NCT05617846 Not yet recruiting - Complication Clinical Trials

Application of Antiosteoporosis Therapy in Osteolysis

Start date: December 28, 2024
Phase:
Study type: Observational

To report the postoperative complications and limb function of patients with osteolysis after surgery for bone tumors of the extremities who received anti-osteoporosis therapy in Henan Cancer Hospital in the next 10 years.

NCT ID: NCT05617690 Recruiting - Clinical trials for Visual Evoked Potentials

Cyclopol on Electrophysiological Monitoring During Spine Surgery: a Randomized Controlled, Noninferiority Study

Start date: April 4, 2023
Phase: N/A
Study type: Interventional

Postoperative visual function injury occurs after spinal cord, neurosurgery, ophthalmology and other operations, which directly affects the postoperative quality of life of patients. Flash visual evoked potential (FVEP) is important for evaluating visual function under general anesthesia during operation. The changes of visual function can be observed and recognized in time through the amplitude changes of FVEP, which can avoid or reduce the visual function damage during operation. Anesthesia method determines the success and variability of electrophysiological monitoring to a certain extent. The purpose of this study is to investigate the effect of total intravenous anesthesia based on cyclopol on FVEP compared with propofol.

NCT ID: NCT05617677 Recruiting - Clinical trials for Systemic Lupus Erythematosus

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

POETYK SLE-1
Start date: January 12, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population.

NCT ID: NCT05617573 Completed - Clinical trials for Osteoarthritis, Knee

Synovitis in Patients With Osteoarthritis

Start date: November 1, 2020
Phase:
Study type: Observational

To study synovial membrane (SM) inflammation in suprapatellar fossa in advanced knee osteoarthritis (OA), and to correlate the pathological features with clinical findings.

NCT ID: NCT05617469 Recruiting - Gastric Cancer Clinical Trials

DLCS for Predicting Neoadjuvant Chemotherapy Response

Start date: July 1, 2022
Phase:
Study type: Observational

The early noninvasive screening of patients suitable for neoadjuvant chemotherapy (NCT) is essential for personalized treatment in locally advanced gastric cancer (LAGC). The aim of this study was to develop and visualized a radio-clinical biomarker from pretreatment oversampled CT images to predict the response and prognosis to NCT in LAGC patients.

NCT ID: NCT05617430 Recruiting - Clinical trials for Hepatocellular Carcinoma

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

Start date: November 2, 2022
Phase: Phase 2
Study type: Interventional

This is a single-arm, exploratory study to evaluate the efficacy and safety of HAIC in combination with sintilimab and bevacizumab in the first line treatment of patients with BCLC-C hepatocellular carcinoma.